End-of-day prices provided by Twelve Data · One close per session. Not real time and not a quote.
Recorded SEC filings in plain language — not advice or a prediction.
Sale intention announced
On Aug 11, Cambrian BioPharma Inc filed notice of intent to sell up to $3.6M. That is about 9.71% of shares outstanding.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
No sale of theirs is on record yet in Form 4; the 90-day window is still open.
Beta
Scores, historical analogues, watchlist and Radar work over the same companies you can already browse here.
Invite-only beta. Payments are not active yet.
13 older filings not shown · The record reaches back to Apr 5, 21.
Stress disclosed to the SEC that the timeline above does not reach, by age. Not a timeline: these are the individual facts, with no claim that nothing else sat between them.
The full record holds 5 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Passive holders
Filed on Schedule 13G: large stakes held without an intention to control — mostly index and institutional funds.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
421 filings on record, the oldest from Dec 9, 20.
Listing the 25 most recent filings of the 421 on record.
There are 24 more transactions in this stretch.
Tax, stock compensation and option exercises. These are not decisions to buy or sell, so they sit apart and never enter the totals above. The amount can be huge without meaning conviction.
The full record holds 128 transactions and goes back to Jun 10, 22.
